Geology Team Enlists Industry's Help In Pursuing Earth-Shaking Research

Jack E. Oliver took two major risks 17 years ago when he moved from Columbia University to Cornell University to rebuild the geology program. First he proposed a research project that relied on an untested scientific technique. Then he proposed an unusual strategy for carrying out the fieldwork. In his quest to probe the 25-mile-thick slab of rock that makes up the earth’s crust, Oliver wanted to use sound waves to describe subterranean structures. But he didn’t buy the fleet of

Written byAnne Moffat
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Jack E. Oliver took two major risks 17 years ago when he moved from Columbia University to Cornell University to rebuild the geology program. First he proposed a research project that relied on an untested scientific technique. Then he proposed an unusual strategy for carrying out the fieldwork.

In his quest to probe the 25-mile-thick slab of rock that makes up the earth’s crust, Oliver wanted to use sound waves to describe subterranean structures. But he didn’t buy the fleet of 18-ton trucks equipped with mechanical vibrations to shake the earth that he needed for the study. Nor did he buy the thousands of “geophones” needed to listen to the earth’s response to the artificial vibrations. And he didn’t hire a huge team of geologists to gather data in the field, either.

So how have he and his 30-member team managed to continually churn out new findings, such as their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies